Legislature(2017 - 2018)CAPITOL 106

04/11/2017 03:00 PM HEALTH & SOCIAL SERVICES

Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.

Download Mp3. <- Right click and save file as
Download Video part 1. <- Right click and save file as

* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
*+ HB 118 COMPENSATION FOR WRONGFUL CONVICTION TELECONFERENCED
Heard & Held
-- Testimony <Invitation Only> --
+ SB 32 PRESCRIPTIONS FOR BIOLOGICAL PRODUCTS TELECONFERENCED
Heard & Held
-- Testimony <Invitation Only> --
+ Bills Previously Heard/Scheduled TELECONFERENCED
+= HB 159 OPIOIDS;PRESCRIPTIONS;DATABASE;LICENSES TELECONFERENCED
Moved CSHB 159(HSS) Out of Committee
+= HB 25 INSURANCE COVERAGE FOR CONTRACEPTIVES TELECONFERENCED
Moved CSHB 25(HSS) Out of Committee
                    ALASKA STATE LEGISLATURE                                                                                  
      HOUSE HEALTH AND SOCIAL SERVICES STANDING COMMITTEE                                                                     
                         April 11, 2017                                                                                         
                           3:06 p.m.                                                                                            
                                                                                                                                
MEMBERS PRESENT                                                                                                               
                                                                                                                                
Representative Ivy Spohnholz, Chair                                                                                             
Representative Bryce Edgmon, Vice Chair                                                                                         
Representative Sam Kito                                                                                                         
Representative Geran Tarr                                                                                                       
Representative David Eastman                                                                                                    
Representative Jennifer Johnston                                                                                                
Representative Colleen Sullivan-Leonard                                                                                         
                                                                                                                                
MEMBERS ABSENT                                                                                                                
                                                                                                                                
Representative Matt Claman (alternate)                                                                                          
Representative Dan Saddler (alternate)                                                                                          
                                                                                                                                
COMMITTEE CALENDAR                                                                                                            
                                                                                                                                
HOUSE BILL NO. 159                                                                                                              
"An  Act relating  to the  prescription of  opioids; establishing                                                               
the   Voluntary  Nonopioid   Directive  Act;   relating  to   the                                                               
controlled  substance  prescription  database;  relating  to  the                                                               
practice  of dentistry;  relating  to the  practice of  medicine;                                                               
relating to  the practice of  podiatry; relating to  the practice                                                               
of osteopathy; relating  to the practice of  nursing; relating to                                                               
the  practice   of  optometry;  relating   to  the   practice  of                                                               
veterinary  medicine;  related to  the  duties  of the  Board  of                                                               
Pharmacy; and providing for an effective date."                                                                                 
                                                                                                                                
     - MOVED CSHB 159(HSS) OUT OF COMMITTEE                                                                                     
                                                                                                                                
HOUSE BILL NO. 25                                                                                                               
"An  Act relating  to insurance  coverage for  contraceptives and                                                               
related  services; relating  to medical  assistance coverage  for                                                               
contraceptives  and  related  services;   and  providing  for  an                                                               
effective date."                                                                                                                
                                                                                                                                
     - MOVED CSHB 25(HSS) OUT OF COMMITTEE                                                                                      
                                                                                                                                
HOUSE BILL NO. 118                                                                                                              
"An  Act relating  to compensation  for  wrongful conviction  and                                                               
imprisonment."                                                                                                                  
                                                                                                                                
     - HEARD & HELD                                                                                                             
                                                                                                                                
SENATE BILL NO. 32                                                                                                              
"An Act relating to biological products; relating to the                                                                        
practice of pharmacy; relating to the Board of Pharmacy; and                                                                    
providing for an effective date."                                                                                               
                                                                                                                                
     - HEARD & HELD                                                                                                             
                                                                                                                                
PREVIOUS COMMITTEE ACTION                                                                                                     
                                                                                                                                
BILL: HB 159                                                                                                                  
SHORT TITLE: OPIOIDS;PRESCRIPTIONS;DATABASE;LICENSES                                                                            
SPONSOR(s): RULES BY REQUEST OF THE GOVERNOR                                                                                    
                                                                                                                                
03/06/17       (H)       READ THE FIRST TIME - REFERRALS                                                                        
03/06/17       (H)       HSS, FIN                                                                                               
03/18/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
03/18/17       (H)       Heard & Held                                                                                           
03/18/17       (H)       MINUTE(HSS)                                                                                            
03/25/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
03/25/17       (H)       -- MEETING CANCELED --                                                                                 
03/30/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
03/30/17       (H)       Heard & Held                                                                                           
03/30/17       (H)       MINUTE(HSS)                                                                                            
04/04/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
04/04/17       (H)       Scheduled but Not Heard                                                                                
04/08/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
04/08/17       (H)       -- MEETING CANCELED --                                                                                 
04/11/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
                                                                                                                                
BILL: HB 25                                                                                                                   
SHORT TITLE: INSURANCE COVERAGE FOR CONTRACEPTIVES                                                                              
SPONSOR(s): CLAMAN                                                                                                              
                                                                                                                                
01/18/17       (H)       PREFILE RELEASED 1/9/17                                                                                
01/18/17       (H)       READ THE FIRST TIME - REFERRALS                                                                        
01/18/17       (H)       HSS, FIN                                                                                               
02/28/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
02/28/17       (H)       Heard & Held                                                                                           
02/28/17       (H)       MINUTE(HSS)                                                                                            
03/09/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
03/09/17       (H)       Heard & Held                                                                                           
03/09/17       (H)       MINUTE(HSS)                                                                                            
04/06/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
04/06/17       (H)       Scheduled but Not Heard                                                                                
04/08/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
04/08/17       (H)       -- MEETING CANCELED --                                                                                 
04/11/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
                                                                                                                                
BILL: HB 118                                                                                                                  
SHORT TITLE: COMPENSATION FOR WRONGFUL CONVICTION                                                                               
SPONSOR(s): KAWASAKI                                                                                                            
                                                                                                                                
02/13/17       (H)       READ THE FIRST TIME - REFERRALS                                                                        
02/13/17       (H)       HSS, JUD, FIN                                                                                          
04/11/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
                                                                                                                                
BILL: SB 32                                                                                                                   
SHORT TITLE: PRESCRIPTIONS FOR BIOLOGICAL PRODUCTS                                                                              
SPONSOR(s): HUGHES                                                                                                              
                                                                                                                                
01/23/17       (S)       READ THE FIRST TIME - REFERRALS                                                                        
01/23/17       (S)       HSS, L&C                                                                                               
02/10/17       (S)       HSS AT 1:30 PM BUTROVICH 205                                                                           
02/10/17       (S)       Heard & Held                                                                                           
02/10/17       (S)       MINUTE(HSS)                                                                                            
02/15/17       (S)       HSS AT 1:30 PM BUTROVICH 205                                                                           
02/15/17       (S)       Moved SB 32 Out of Committee                                                                           
02/15/17       (S)       MINUTE(HSS)                                                                                            
02/17/17       (S)       HSS RPT 2DP 1NR 1AM                                                                                    
02/17/17       (S)       NR: WILSON                                                                                             
02/17/17       (S)       DP: VON IMHOF, BEGICH                                                                                  
02/17/17       (S)       AM: GIESSEL                                                                                            
03/07/17       (S)       L&C AT 1:30 PM BELTZ 105 (TSBldg)                                                                      
03/07/17       (S)       Heard & Held                                                                                           
03/07/17       (S)       MINUTE(L&C)                                                                                            
03/14/17       (S)       L&C AT 1:30 PM BELTZ 105 (TSBldg)                                                                      
03/14/17       (S)       Moved SB 32 Out of Committee                                                                           
03/14/17       (S)       MINUTE(L&C)                                                                                            
03/15/17       (S)       L&C RPT  5DP                                                                                           
03/15/17       (S)       DP: COSTELLO, HUGHES, MEYER, STEVENS,                                                                  
                         GARDNER                                                                                                
03/15/17       (S)       FIN REFERRAL ADDED AFTER L&C                                                                           
03/29/17       (S)       FIN AT 9:00 AM SENATE FINANCE 532                                                                      
03/29/17       (S)       Heard & Held                                                                                           
03/29/17       (S)       MINUTE(FIN)                                                                                            
03/30/17       (S)       FIN AT 9:00 AM SENATE FINANCE 532                                                                      
03/30/17       (S)       Moved SB 32 Out of Committee                                                                           
03/30/17       (S)       MINUTE(FIN)                                                                                            
03/31/17       (S)       FIN AT 1:30 PM SENATE FINANCE 532                                                                      
03/31/17       (S)       -- MEETING CANCELED --                                                                                 
04/03/17       (S)       FIN RPT  1DP 3NR 1AM                                                                                   
04/03/17       (S)       NR: MACKINNON, BISHOP, DUNLEAVY                                                                        
04/03/17       (S)       DP: VON IMHOF                                                                                          
04/03/17       (S)       AM: OLSON                                                                                              
04/04/17       (S)       TRANSMITTED TO (H)                                                                                     
04/04/17       (S)       VERSION: SB  32                                                                                        
04/05/17       (H)       READ THE FIRST TIME - REFERRALS                                                                        
04/05/17       (H)       HSS, FIN                                                                                               
04/11/17       (H)       HSS AT 3:00 PM CAPITOL 106                                                                             
                                                                                                                                
WITNESS REGISTER                                                                                                              
                                                                                                                                
JAY BUTLER, M.D., Chief Medical Officer/Director                                                                                
Central Office                                                                                                                  
Division of Public Health (DPH)                                                                                                 
Department of Health and Social Services (DHSS)                                                                                 
Anchorage, Alaska                                                                                                               
POSITION STATEMENT:  Answered questions during the discussion of                                                              
HB 159.                                                                                                                         
                                                                                                                                
REPRESENTATIVE MATT CLAMAN                                                                                                      
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Presented the proposed CS for HB 25, as                                                                  
prime sponsor of the bill.                                                                                                      
                                                                                                                                
LIZZIE KUBBITZ, Staff                                                                                                           
Representative Matt Claman                                                                                                      
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Presented the changes to HB 25, on behalf                                                                
of the prime sponsor, Representative Claman.                                                                                    
                                                                                                                                
ANNA LATHAM, Deputy Director                                                                                                    
Juneau Office                                                                                                                   
Division of Insurance                                                                                                           
Department of Commerce, Community & Economic Development (DCCED)                                                                
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Answered questions during discussion of HB                                                               
25.                                                                                                                             
                                                                                                                                
MICHELE MICHAUD, Chief Health Official                                                                                          
Central Office                                                                                                                  
Division of Retirement and Benefits (DRB)                                                                                       
Department of Administration (DOA)                                                                                              
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Answered questions during discussion of HB                                                               
25.                                                                                                                             
                                                                                                                                
OLIVIA GARRETT, Staff                                                                                                           
Representative Scott Kawasaki                                                                                                   
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Presented HB 118 on behalf of the prime                                                                  
sponsor, Representative Kawasaki.                                                                                               
                                                                                                                                
KACI SCHROEDER, Assistant Attorney General                                                                                      
Legal Services Section                                                                                                          
Criminal Division                                                                                                               
Department of Law                                                                                                               
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Answered questions during discussion of HB                                                               
118.                                                                                                                            
                                                                                                                                
BARBARA BRINK                                                                                                                   
Alaska Innocence Project                                                                                                        
Anchorage, Alaska                                                                                                               
POSITION STATEMENT:  Testified during discussion of HB 118.                                                                   
                                                                                                                                
DON HABEGER, Community Coordinator                                                                                              
Juneau Reentry Coalition                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Testified during discussion of HB 118.                                                                   
                                                                                                                                
DIANE CASTO, Behavioral Health Policy Advisor                                                                                   
Division of Behavioral Health                                                                                                   
Department of Health and Social Services                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Testified during discussion of HB 118.                                                                   
                                                                                                                                
SENATOR SHELLEY HUGHES                                                                                                          
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Presented SB 32 as prime sponsor.                                                                        
                                                                                                                                
THOMAS FELIX, M.D.                                                                                                              
AMGEN                                                                                                                           
Washington, DC                                                                                                                  
POSITION STATEMENT:  Testified during discussion of SB 32.                                                                    
                                                                                                                                
AIMEE BUSHNELL, Staff                                                                                                           
Senator Shelley Hughes                                                                                                          
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Presented SB 32 on behalf of the prime                                                                   
sponsor, Senator Hughes.                                                                                                        
                                                                                                                                
ACTION NARRATIVE                                                                                                              
                                                                                                                                
3:06:25 PM                                                                                                                    
                                                                                                                                
CHAIR IVY SPOHNHOLZ  called the House Health  and Social Services                                                             
Standing   Committee    meeting   to    order   at    3:06   p.m.                                                               
Representatives  Spohnholz,   Sullivan-Leonard,  Kito,  Johnston,                                                               
Edgmon,   and  Tarr   were  present   at  the   call  to   order.                                                               
Representative Eastman arrived as the meeting was in progress.                                                                  
                                                                                                                                
         HB 159-OPIOIDS;PRESCRIPTIONS;DATABASE;LICENSES                                                                     
                                                                                                                                
3:07:44 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced that the  first order of business would                                                               
be HOUSE  BILL NO. 159, "An  Act relating to the  prescription of                                                               
opioids;  establishing  the  Voluntary Nonopioid  Directive  Act;                                                               
relating  to  the  controlled  substance  prescription  database;                                                               
relating to the  practice of dentistry; relating  to the practice                                                               
of medicine;  relating to the  practice of podiatry;  relating to                                                               
the practice of osteopathy; relating  to the practice of nursing;                                                               
relating to the  practice of optometry; relating  to the practice                                                               
of veterinary  medicine; related  to the duties  of the  Board of                                                               
Pharmacy; and providing for an effective date."                                                                                 
                                                                                                                                
3:08:04 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  EDGMON  moved  to adopt  the  proposed  committee                                                               
substitute (CS)  for HB 159, labeled  30-GH1021\J, Bruce, 4/6/17,                                                               
as the working draft.                                                                                                           
                                                                                                                                
CHAIR SPOHNHOLZ objected for discussion.                                                                                        
                                                                                                                                
3:08:34 PM                                                                                                                    
                                                                                                                                
JAY  BUTLER,   M.D.,  Chief  Medical   Officer/Director,  Central                                                               
Office,  Division of  Public Health  (DPH), Department  of Health                                                               
and Social  Services (DHSS), said  that Version J  incorporated 4                                                               
amendments to address the core intent  of HB 159 - to address the                                                               
floor of  legal prescription opioids in  Alaska's communities and                                                               
to  improve patient  safety.   The  first amendment  incorporated                                                               
under  Version J,  he noted,  would align  language under  HB 159                                                               
with the federal Comprehensive Addiction  and Recovery Act (CARA)                                                               
to allow partial prescription fills  without requiring voiding of                                                               
the remaining portion of the  prescriptions, as addressed on page                                                               
24, Section  8, of Version  J.   Second, Version J  would clarify                                                               
the role  and responsibilities of  the prescribing  providers and                                                               
pharmacists  filling   the  prescriptions.     He   stated,  "The                                                               
intention of  the bill all  along was that the  responsibility to                                                               
check [the] prescription drug monitoring  program (PDMP) prior to                                                               
writing  new prescriptions  for schedule  II and  III medications                                                               
falls to the prescribers; whereas  ... the responsibility for ...                                                               
populating  the prescription  drug  monitoring  program with  ...                                                               
unfilled prescriptions falls to the pharmacist."                                                                                
                                                                                                                                
DR. BUTLER  said the third  amendment made under Version  J would                                                               
address  the  implementation of  the  PDMP  update frequency;  it                                                               
would delay  implementation of daily  updates until July  2018 in                                                               
order to address  the potential administrative burden  on some of                                                               
the smaller pharmacies.   Finally, he said there  is an amendment                                                               
under  Version J  that  would clarify  the  liability waiver  for                                                               
advance directives  that include  not just failure  to administer                                                               
an opioid but  also the inadvertent administration  of opioids to                                                               
a person who has an  opioids advance directive on his/her medical                                                               
record.  He  said the related language is in  Section 31, on page                                                               
27, of Version J.                                                                                                               
                                                                                                                                
3:11:15 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  SULLIVAN-LEONARD directed  attention to  page 28,                                                               
Sections 32  and 33,  and asked  for clarification  regarding the                                                               
justification  for  amended   language  related  to  correctional                                                               
facilities.                                                                                                                     
                                                                                                                                
3:11:46 PM                                                                                                                    
                                                                                                                                
DR. BUTLER replied  that the reason for  specifically calling out                                                               
correctional facilities is to make  clear the goal of the updated                                                               
PDMP  was never  to include  patients already  institutionalized.                                                               
He  said  much   of  the  focus  has  been  on   people  who  are                                                               
hospitalized.   He said it was  pointed out to his  division that                                                               
it  may  not  be  clear  that  people  who  are  in  correctional                                                               
facilities are  similarly institutionalized.   He said  he thinks                                                               
that what often  has driven the over prescription  of opioids has                                                               
been  misapplication  of  data on  hospitalized  patients,  which                                                               
shows people  in a hospital  receiving opioid medications  are at                                                               
remarkably  low risk  of having  subsequent  substance misuse  or                                                               
addiction  as  opposed to  those  who  receive  the drugs  on  an                                                               
outpatient basis.  He said the  change in language to include the                                                               
correctional facility  is to  clarify that  someone who  is begin                                                               
treated  in the  infirmary of  a correctional  facility during  a                                                               
prolonged   incarceration  is   being  viewed   similarly.     He                                                               
specified,  however,   that  someone  being  discharged   from  a                                                               
correctional  facility on  outpatient  opioids would  need to  be                                                               
monitored under the PDMP.                                                                                                       
                                                                                                                                
3:13:52 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ removed her objection  to the motion to adopt the                                                               
proposed  committee  substitute  (CS)  for HB  159,  labeled  30-                                                               
GH1021\J, Bruce,  4/6/17, as the  working draft.  There  being no                                                               
further  objection, Version  J was  before the  committee as  the                                                               
working draft.                                                                                                                  
                                                                                                                                
3:14:08 PM                                                                                                                    
                                                                                                                                
CHAIR  SPOHNHOLZ noted  that an  issue  had been  brought to  her                                                               
attention regarding  hospitals and emergency rooms  that dispense                                                               
less  than a  24-hour supply  of  opioids to  patients leaving  a                                                               
hospital.  She  said this relates to [Sections 32  and 33], about                                                               
which  Representative Sullivan-Leonard  just queried.   She  said                                                               
these supplies are dispensed as  prepackaged supplies of medicine                                                               
and requiring  such a  small supply  to be  reported to  the PDMP                                                               
would  be  an  "overly  onerous   burden  on  inpatient  hospital                                                               
pharmacies."                                                                                                                    
                                                                                                                                
CHAIR  SPOHNHOLZ   moved  to  adopt  Amendment   1,  labeled  30-                                                               
GH1021\J.1, Bruce, 4/6/17, which read as follows:                                                                               
                                                                                                                                
     Page 28, lines 5 - 7:                                                                                                      
          Delete "those administered to a patient at a                                                                          
        health care facility or a correctional facility,                                                                    
      except when prescribing opioids to an inmate at the                                                                   
     time of the inmate's release"                                                                                          
          Insert "under the circumstances described in (u)                                                                  
     of this section [THOSE ADMINISTERED TO A PATIENT AT A                                                                  
     HEALTH CARE FACILITY]"                                                                                                     
                                                                                                                                
     Page 28, lines 13 - 15:                                                                                                    
          Delete "administered to a patient at a health                                                                         
     care facility or a correctional facility, except when                                                                  
      prescribing opioids to an inmate at the time of the                                                                   
     inmate's release"                                                                                                      
          Insert "dispensed or administered under the                                                                       
         circumstances described in (u) of this section                                                                     
     [ADMINISTERED TO A PATIENT AT A HEALTH CARE FACILITY]"                                                                     
                                                                                                                                
     Page 29, lines 7 - 9:                                                                                                      
          Delete "administered to a patient at a health                                                                         
     care facility or a correctional facility, except when                                                                      
      prescribing opioids to an inmate at the time of the                                                                       
     inmate's release"                                                                                                          
          Insert "dispensed or administered under the                                                                           
     circumstances described in (u) of this section"                                                                            
                                                                                                                                
     Page 32, line 22:                                                                                                          
          Delete "a new subsection"                                                                                             
          Insert "new subsections"                                                                                              
                                                                                                                                
     Page 32, following line 30:                                                                                                
     Insert a new subsection to read:                                                                                           
          "(u)  A practitioner or a pharmacist is not                                                                           
      required to comply with the requirements of (a) and                                                                       
     (b) of this section if a controlled substance is                                                                           
               (1) administered to a patient at                                                                                 
               (A)  a health care facility; or                                                                                  
               (B)  a correctional facility;                                                                                    
               (2)  dispensed to a patient for an                                                                               
     outpatient supply of 24 hours or less at a hospital                                                                        
               (A)  inpatient pharmacy; or                                                                                      
               (B)  emergency department."                                                                                      
                                                                                                                                
     Page 35, following line 11:                                                                                                
     Insert a new bill section to read:                                                                                         
       "* Sec. 51. Section 41 of this Act takes effect on                                                                     
       the effective date of secs. 21 and 23, ch. 25, SLA                                                                       
     2016."                                                                                                                     
                                                                                                                                
     Renumber the following bill sections accordingly.                                                                          
                                                                                                                                
     Page 35, line 15:                                                                                                          
          Delete "secs. 45 - 52"                                                                                                
     Insert "secs. 45 - 53"                                                                                                     
                                                                                                                                
CHAIR SPOHNHOLZ objected  for purposes of discussion.   She asked                                                               
Dr. Butler if he had seen Amendment 1.                                                                                          
                                                                                                                                
DR.  BUTLER said  he had  not seen  the text  of Amendment  1 but                                                               
understood  the  concept of  it.    In  response to  a  follow-up                                                               
question, he  reiterated that the focus  of HB 159 is  to address                                                               
the flood of  opioids into Alaska's communities,  and Amendment 1                                                               
would  address  small dispensing  of  medication.   He  said  the                                                               
current  law   surrounding  the   PDMP  does  not   require  that                                                               
prescribers "check the PDMP" if  dispensing less than a three-day                                                               
supply.   He said the  intent behind  this is to  incentivize the                                                               
subscription of  smaller amounts [of  opioids] and to  reduce the                                                               
administrative  burden.    He surmised  that  Amendment  1  could                                                               
achieve a similar  aim, as concerns the  administrative burden on                                                               
hospital  pharmacies, which  dispense small  amounts through  the                                                               
emergency  departments.   He  indicated  that the  administration                                                               
would not object [to Amendment 1].                                                                                              
                                                                                                                                
3:16:20 PM                                                                                                                    
                                                                                                                                
CHAIR  SPOHNHOLZ removed  her objection  to the  motion to  adopt                                                               
Amendment 1.   There being no further objection,  Amendment 1 was                                                               
adopted.                                                                                                                        
                                                                                                                                
3:16:45 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  EDGMON  moved to  report  CSHB  159, Version  30-                                                               
GH1021\J,  Bruce,  4/6/17,  as amended,  out  of  committee  with                                                               
individual  recommendations and  the  accompanying fiscal  notes.                                                               
There  being no  objection, CSHB  159(HSS) was  moved from  House                                                               
Health and Social Services Standing Committee.                                                                                  
                                                                                                                                
3:17:08 PM                                                                                                                    
                                                                                                                                
The committee took an at-ease from 3:17 p.m. to 3:19 p.m.                                                                       
                                                                                                                                
          HB 25-INSURANCE COVERAGE FOR CONTRACEPTIVES                                                                       
                                                                                                                                
3:19:04 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced  that the next order  of business would                                                               
be HOUSE BILL NO. 25, "An  Act relating to insurance coverage for                                                               
contraceptives   and  related   services;  relating   to  medical                                                               
assistance coverage for contraceptives  and related services; and                                                               
providing for an effective date."                                                                                               
                                                                                                                                
3:19:33 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  EDGMON  moved  to adopt  the  proposed  committee                                                               
substitute  (CS)   for  HB  25,  labeled   30-LS0261\J,  Wallace,                                                               
3/31/17, as the working draft.                                                                                                  
                                                                                                                                
3:19:41 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ objected for discussion.                                                                                        
                                                                                                                                
3:19:55 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  MATT  CLAMAN,  Alaska State  Legislature,  stated                                                               
that proposed  HB 25 sought  to make  prescriptive contraceptives                                                               
more  easily available  by mandating  that  health care  insurers                                                               
provide coverage for  a 12-month supply of  contraceptives at one                                                               
time.   He reported that  his office had worked  with individuals                                                               
from the  Division of Insurance, (Department  of Administration),                                                               
and the Department of Law  to find language which captured active                                                               
state employee  programs and  allowed insurers  and the  state to                                                               
apply   reasonable  medical   management   techniques  and   cost                                                               
containment    strategies    when    providing    coverage    for                                                               
contraceptives.                                                                                                                 
                                                                                                                                
3:20:43 PM                                                                                                                    
                                                                                                                                
LIZZIE KUBBITZ,  Staff, Representative Matt Claman,  Alaska State                                                               
Legislature, paraphrased the changes  made to Version J [Included                                                               
in members' packets], which read:                                                                                               
                                                                                                                                
     "An   Act   relating    to   insurance   coverage   for                                                                    
     contraceptives  and   related  services;   relating  to                                                                    
     medical  assistance  coverage  for  contraceptives  and                                                                    
     related  services;  and   providing  for  an  effective                                                                    
     date."                                                                                                                     
                                                                                                                                
     Section 1   Amends AS  21.42.427(d) to give health care                                                                  
     insurers   the  ability   to   enact  reasonable   cost                                                                    
     containment measures and provides  a definition of cost                                                                    
     containment.  Adds a  new subsection  (e) which  states                                                                    
     that if the  covered therapeutically equivalent version                                                                    
     of a prescription contraceptive  is not available or is                                                                    
     considered   medically  inadvisable,   a  health   care                                                                    
     provider  shall provide  coverage without  cost sharing                                                                    
     for   an  alternative   version  of   the  prescription                                                                    
     contraceptive.                                                                                                             
                                                                                                                                
     Section  2    Amends AS  39.30.090(a) by  adding a  new                                                                  
     subsection (13)  to include: "a group  health insurance                                                                    
     policy   covering   employees    of   a   participating                                                                    
     governmental unit is subject  to the requirements of AS                                                                    
     21.42.427."                                                                                                                
                                                                                                                                
     Section 3    Amends AS  39.30.091 to include:  "a self-                                                                  
     insured  group medical  plan covering  active employees                                                                    
     provided  under   this  section   is  subject   to  the                                                                    
     requirements of 21.42.427."                                                                                                
                                                                                                                                
3:23:34 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON asked  if  all  state employees,  except                                                               
retirees, as  well as other  public employees, would  be covered.                                                               
She asked  which programs would  not be covered by  this proposed                                                               
bill.                                                                                                                           
                                                                                                                                
MS.  KUBBITZ replied  that the  Department of  Administration had                                                               
advised  the sponsor  to  only attempt  to  capture active  state                                                               
employees.                                                                                                                      
                                                                                                                                
REPRESENTATIVE  JOHNSTON asked  if  this would  apply to  private                                                               
employer programs.                                                                                                              
                                                                                                                                
MS.  KUBBITZ  reiterated that  AS  39  would only  capture  state                                                               
employees;  however, other  portions of  the proposed  bill would                                                               
apply to Medicaid  and private employers.  She  said that Version                                                               
J would ensure that active state employees were included.                                                                       
                                                                                                                                
REPRESENTATIVE  JOHNSTON  asked  about  other  public  employees,                                                               
including the self-insured Municipality of Anchorage.                                                                           
                                                                                                                                
MS.  KUBBITZ said  that  she  would defer  that  question to  the                                                               
Department  of  Administration.    She offered  her  belief  that                                                               
municipal  employees had  not been  included in  any of  the bill                                                               
discussions.                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON  expressed   her  concern  that  private                                                               
individuals and companies were  required to participate, although                                                               
state employees had been excluded.   She stated that "I am trying                                                               
to look for what is fair is fair."                                                                                              
                                                                                                                                
3:26:57 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  CLAMAN pointed  out that  the proposed  Version J                                                               
specifically addressed  earlier questions  for coverage  to state                                                               
employees.   He opined  that it would  get even  more complicated                                                               
for coverage  of municipalities, although many  of these programs                                                               
participated in state  programs, even though it  was not intended                                                               
to give them an out.                                                                                                            
                                                                                                                                
REPRESENTATIVE JOHNSTON  declared that it would  be necessary for                                                               
this to be addressed.                                                                                                           
                                                                                                                                
3:28:29 PM                                                                                                                    
                                                                                                                                
ANNA  LATHAM,   Deputy  Director,  Juneau  Office,   Division  of                                                               
Insurance,   Department  of   Commerce,   Community  &   Economic                                                               
Development  (DCCED), in  response to  earlier questions,  stated                                                               
that the  proposed bill did  not cover municipal  plans, although                                                               
other  vetted language  could  be  added to  include  them.   She                                                               
offered  her belief  that the  sponsor only  intended to  include                                                               
active state employees.                                                                                                         
                                                                                                                                
3:29:18 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE JOHNSTON directed attention to  page 5, lines 28 -                                                               
29, which  stated that a  group health  policy was subject  to AS                                                               
21.42.427 and asked if this would cover the municipalities.                                                                     
                                                                                                                                
3:30:05 PM                                                                                                                    
                                                                                                                                
MS. LATHAM opined  that this would not  cover municipalities, but                                                               
she deferred to the Department of Law.                                                                                          
                                                                                                                                
REPRESENTATIVE JOHNSTON  asked if  this would  also apply  to the                                                               
government bargaining units.                                                                                                    
                                                                                                                                
3:30:58 PM                                                                                                                    
                                                                                                                                
MICHELE MICHAUD, Chief Health  Official, Central Office, Division                                                               
of Retirement  and Benefits  (DRB), Department  of Administration                                                               
(DOA),  in response,  stated that  the Municipality  of Anchorage                                                               
was not currently  participating, although it could.   She stated                                                               
that there were union health  trusts which were not covered under                                                               
the Alaska Care  plan, as they were  exempted through regulation,                                                               
and these would also not be covered under the proposed bill.                                                                    
                                                                                                                                
3:32:02 PM                                                                                                                    
                                                                                                                                
The committee took a brief at ease.                                                                                             
                                                                                                                                
3:32:25 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ  removed her objection.   There being  no further                                                               
objection, Version J was adopted as the working draft.                                                                          
                                                                                                                                
3:32:59 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON   expressed  her  concern   that  moving                                                               
forward a certain  element of the population  would be segregated                                                               
out.   She said that  she would probably be  a no vote  and would                                                               
recommend an amendment.                                                                                                         
                                                                                                                                
3:33:28 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE SULLIVAN-LEONARD said that  she struggled with the                                                               
mandate aspect  of the proposed legislation  for certain coverage                                                               
of  contraceptives, and  she could  not conceptually  support the                                                               
legislation.                                                                                                                    
                                                                                                                                
3:34:29 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  EDGMON  moved  to  report CSHB  25,  Version  30-                                                               
LS0261\J,  Wallace, 3/31/17,  out  of  committee with  individual                                                               
recommendations and the accompanying fiscal notes.                                                                              
                                                                                                                                
3:34:41 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE EASTMAN objected.  He  said that much of the early                                                               
testimony  dealt  with  obtaining   prescriptions,  and  yet  the                                                               
proposed bill was much broader  based, directing attention to the                                                               
voluntary    sterilization    procedures,   the    consultations,                                                               
examinations, procedures,  and medical services.   He opined that                                                               
the State  of Alaska should  not require that  insurance coverage                                                               
be provided for these items.                                                                                                    
                                                                                                                                
3:35:41 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE EASTMAN maintained his objection.                                                                                
                                                                                                                                
3:35:46 PM                                                                                                                    
                                                                                                                                
A roll call  vote was taken.   Representatives Spohnholz, Edgmon,                                                               
Kito,  and Tarr  voted  in  favor of  CSHB  25.   Representatives                                                               
Sullivan-Leonard,  Eastman,   and  Johnston  voted   against  it.                                                               
Therefore, CSHB 25(HSS) was reported  out of the House Health and                                                               
Social Services Standing Committee by a vote of 4 yeas-3 nays.                                                                  
                                                                                                                                
3:36:21 PM                                                                                                                    
                                                                                                                                
The committee took an at-ease from 3:36 p.m. to 3:39 p.m.                                                                       
                                                                                                                                
          HB 118-COMPENSATION FOR WRONGFUL CONVICTION                                                                       
                                                                                                                                
3:39:18 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced  that the next order  of business would                                                               
be  HOUSE BILL  NO. 118,  "An  Act relating  to compensation  for                                                               
wrongful conviction and imprisonment."                                                                                          
                                                                                                                                
3:39:46 PM                                                                                                                    
                                                                                                                                
OLIVIA  GARRETT,  Staff,  Representative Scott  Kawasaki,  Alaska                                                               
State Legislature,  presented proposed  HB 118  on behalf  of the                                                               
bill sponsor,  Representative Kawasaki.   She stated that  HB 118                                                               
would create  an administrative  process so  that those  who were                                                               
wrongfully convicted  of crimes  and subsequently served  time in                                                               
prison would be  able to apply for compensation  for time served.                                                               
She  paraphrased   from  the  Sectional  Analysis   [Included  in                                                               
members' packets], which read:                                                                                                  
                                                                                                                                
     Section 1.  Amends AS 44.29.20  by adding  a subsection                                                                  
     that  directs  the  Department  of  Health  and  Social                                                                    
     Services  to establish  a  re-entry  program to  assist                                                                    
     wrongfully  convicted   persons  in   obtaining  mental                                                                    
     health   services,   including  treatment   for   post-                                                                    
     traumatic stress disorder.                                                                                                 
                                                                                                                                
     Section 2.  Provides that every claim  of reimbursement                                                                  
     for  wrongful  conviction  and  imprisonment  shall  be                                                                    
     promptly  presented to  the appropriate  administrative                                                                    
     or  executive officer  of a  department  or branch  for                                                                    
     approval or payment.                                                                                                       
                                                                                                                                
     Section 3.                                                                                                               
                                                                                                                                
     (a) Establishes  that a person  must file a  claim with                                                                    
     the attorney general to  receive compensation, and must                                                                    
     show by  preponderance of the  evidence that  they were                                                                    
     convicted of  one or  more offenses  and served  any or                                                                    
     all of the resulting sentence and:                                                                                         
                                                                                                                                
     (1) either  the conviction  for the  resulting sentence                                                                    
     was  vacated or  reversed  and the  charges were  later                                                                    
     dismissed  or  the person  was  retried  and found  not                                                                    
     guilty, or the person was pardoned.                                                                                        
                                                                                                                                
     (2)  the person  did not  commit any  of the  crimes of                                                                    
     which they were convicted,  commit perjury, get another                                                                    
     person  to  commit  perjury or  fabricate  evidence.  A                                                                    
     false confession,  admission, or  guilty plea  does not                                                                    
     entitle   a  person   to   compensation  for   wrongful                                                                    
     conviction.                                                                                                                
                                                                                                                                
     (b) States  that compensation for  wrongful convictions                                                                    
     only extends to the specific  case and does not include                                                                    
     compensation for a concurrent sentence.                                                                                    
                                                                                                                                
     (c) States that  individuals receiving compensation for                                                                    
     wrongful  conviction will  receive $50,000  dollars for                                                                    
     each year  of imprisonment  up to  a lifetime  total of                                                                    
     $2,000,000.                                                                                                                
                                                                                                                                
     (d) States that a  person who has received compensation                                                                    
     for wrongful conviction by the  State of Alaska may not                                                                    
     bring   any   further   action    to   the   state   or                                                                    
     municipalities  regarding the  same subject  matter for                                                                    
     which they have received compensation.                                                                                     
                                                                                                                                
     (e) States  that an  individual must  file a  claim for                                                                    
     compensation  within 2  years after  their exoneration,                                                                    
     however the attorney general  may authorize payment for                                                                    
     a claim  filed past  that time  if they  determine that                                                                    
     there is good cause for delay.                                                                                             
                                                                                                                                
     (f)  Lists  social  services   and  programs  a  person                                                                    
     receiving  compensation  for   wrongful  conviction  is                                                                    
     entitled to.                                                                                                               
                                                                                                                                
     1) Reentry  services as provided  by the  Department of                                                                    
     Health and Social Services under AS 44.29.020.                                                                             
                                                                                                                                
     2) Tuition and fees at  any University of Alaska campus                                                                    
     for themselves  and any  children or  stepchildren ages                                                                    
     17-26.                                                                                                                     
                                                                                                                                
     3)   3  years   of   job   training  services   through                                                                    
     appropriate state programs.                                                                                                
                                                                                                                                
     4) Up to 10 years of state funded healthcare coverage.                                                                     
                                                                                                                                
     5) Economic  damages including lost wages  and attorney                                                                    
     fees.                                                                                                                      
                                                                                                                                
     (g) States  that all  compensation provided  under this                                                                    
     section, except  for awarded  attorney fees,  is exempt                                                                    
     from taxation  and that  it may not  be used  to offset                                                                    
     expenses incurred  by the  state in  providing services                                                                    
     to the person during their imprisonment.                                                                                   
                                                                                                                                
     Section  4.  The  claimant   may  appeal  the  decision                                                                  
     through the  Department of Administration and  they may                                                                    
     obtain  a judicial  review of  the decision.  Amends AS                                                                    
     44.77.040(c) so that  anyone who is denied  a claim for                                                                    
     wrongful  conviction  compensation  is  prevented  from                                                                    
     taking further  action against the  state for  the same                                                                    
     claim.                                                                                                                     
                                                                                                                                
     Section 5.  Claims made  for compensation  for wrongful                                                                  
     convictions  fall under  claims and  appeals procedures                                                                    
     under AS  44.77.010- 44.77.060 even if  a department or                                                                    
     branch   already  has   separate  claims   and  appeals                                                                    
     procedures.                                                                                                                
                                                                                                                                
3:43:44 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON  asked  for  the  list  of  states  that                                                               
already had some form of the proposed bill.                                                                                     
                                                                                                                                
MS. GARRETT, in  response, offered her belief that  31 states, as                                                               
well  as   the  District  of  Columbia,   provided  for  wrongful                                                               
conviction compensation.                                                                                                        
                                                                                                                                
REPRESENTATIVE JOHNSTON  asked how this would  integrate into the                                                               
court  system.   She  offered  her belief  that  once a  wrongful                                                               
conviction was recognized by the  courts, it became a legal issue                                                               
for how to  compensate and what was done in  each matter, as part                                                               
of  the  settlement.    She  asked if  the  proposed  bill  would                                                               
supersede any legal discussion.                                                                                                 
                                                                                                                                
MS. GARRETT asked for further clarification.                                                                                    
                                                                                                                                
REPRESENTATIVE JOHNSTON  opined that  there had  been negotiation                                                               
and settlement at the court level.                                                                                              
                                                                                                                                
3:45:45 PM                                                                                                                    
                                                                                                                                
KACI  SCHROEDER,  Assistant   Attorney  General,  Legal  Services                                                               
Section,  Criminal   Division,  Department  of  Law,   asked  for                                                               
clarification of the question.                                                                                                  
                                                                                                                                
REPRESENTATIVE  JOHNSTON  in  response,  questioned  whether  the                                                               
legal process for wrongful conviction  would be superseded by the                                                               
proposed bill,  and she expressed  her concern that  the proposed                                                               
bill was overstepping.                                                                                                          
                                                                                                                                
MS.  SCHROEDER stated  that the  department did  not see  this as                                                               
limiting anything in the settlement context.                                                                                    
                                                                                                                                
3:47:36 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON  asked if,  in  other  states with  this                                                               
legislation,  had  this  decreased   the  state's  liability  for                                                               
wrongful convictions.                                                                                                           
                                                                                                                                
MS. GARRETT  replied that  she did not  have the  information but                                                               
that she would provide it to the members.                                                                                       
                                                                                                                                
3:48:31 PM                                                                                                                    
                                                                                                                                
BARBARA BRINK,  Alaska Innocence  Project, stated her  support of                                                               
the proposed  bill.   She shared  her background  as a  state and                                                               
federal  public defender  for more  than  30 years,  representing                                                               
indigent people who were accused of  crimes and then tried in the                                                               
state and federal  courts.  She offered her belief,  in review of                                                               
compensation  statutes in  other states,  that the  proposed bill                                                               
had taken  "the best bits that  other states have tried,  and not                                                               
taken the parts  that haven't been successful."   She opined that                                                               
32 states and  the federal government "already try  to make whole                                                               
those  who have  been  wrongfully convicted  and then  exonerated                                                               
with their own compensation statutes."   She pointed out that the                                                               
proposed  bill would  fill a  recognized  need for  Alaska.   She                                                               
stated that  the proposal to  provide a reentry  service program,                                                               
assist with  job training  and skills, tuition  and fees,  and 10                                                               
years of  health insurance were  especially needed when  a person                                                               
was released from  custody after a long  period of incarceration.                                                               
She  noted  that  these  people  had  lost  touch  with  societal                                                               
expectations,  pointing  out  how  difficult this  could  be  for                                                               
someone.  She  reported that the annual  $50,000 compensation was                                                               
in the  "middle of the  pack of what other  jurisdictions provide                                                               
for the  wrongfully convicted."   She offered some  examples from                                                               
California, Texas, and  Colorado.  She reported  that the federal                                                               
government  paid  $50,000 for  each  year  of incarceration,  and                                                               
$100,000 for  each year if  someone had been  on death row.   She                                                               
added that  most states  allowed for  inflation adjustment.   She                                                               
offered  her  belief  that  it  was  beneficial  to  have  public                                                               
recognition by  the government for  the harm inflicted  on people                                                               
who  were wrongfully  convicted.   She stated  that the  proposed                                                               
bill was  an assurance  to the public  that the  state government                                                               
would  take ownership  of  the  errors, and  that  the state  was                                                               
working to ensure  the integrity of the  criminal justice system.                                                               
She  opined that  this  was good  for  the state,  as  it was  an                                                               
exclusive  remedy,  comparing  it to  the  workers'  compensation                                                               
statute.   She pointed out  that this could reduce  the liability                                                               
for a state  as it would no longer be  bombarded by lawsuits from                                                               
those  who  had  been  exonerated.   She  reported  that  it  was                                                               
estimated that  between 8  and 12 percent  of individuals  in the                                                               
criminal  justice  system had  been  wrongfully  convicted.   She                                                               
stated  that this  was a  uniform, fair,  equitable procedure  to                                                               
allow for some compensation for the wrong that had been done.                                                                   
                                                                                                                                
3:53:53 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE TARR asked for other examples of cases.                                                                          
                                                                                                                                
MS. BRINK  replied that the  Fairbanks 4  case was the  only case                                                               
the  Innocence Project  had obtained  in Alaska  for exoneration.                                                               
She   noted  that   the  appellate   process  could   also  bring                                                               
exoneration,  although she  had  no records  for  the numbers  of                                                               
cases each year.                                                                                                                
                                                                                                                                
3:54:56 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ  shared that the proposed  bill simplified things                                                               
from the state  perspective as it allowed exact  knowledge of the                                                               
promises to those wrongfully convicted.   She asked if there were                                                               
any specific elements  which were key to  ensure people's success                                                               
to get over the trauma for loss of freedom as they move forward.                                                                
                                                                                                                                
3:56:02 PM                                                                                                                    
                                                                                                                                
MS. BRINK, in response, said  that the first provision to provide                                                               
assistance through  the Department of Health  and Social Services                                                               
was one  that many states  had neglected to include,  noting that                                                               
even  financial   compensation  did  not  guarantee   success  to                                                               
exonerees.   She offered  her belief that  the proposed  bill did                                                               
well in  setting forth  the grounds  that would  show exoneration                                                               
and what would  not demonstrate exclusion.  She  lauded Section 3                                                               
which  covered all  the  issues  which had  gone  wrong in  other                                                               
states.                                                                                                                         
                                                                                                                                
3:57:36 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  JOHNSTON  asked  about the  indeterminate  fiscal                                                               
note,  and  she  asked  about   the  payments  made  outside  the                                                               
Department of Law's operating appropriation.   She asked what the                                                               
source of funds would be.                                                                                                       
                                                                                                                                
3:58:33 PM                                                                                                                    
                                                                                                                                
MS.  SCHROEDER, in  response, explained  that this  would clarify                                                               
that  the payments  would not  come  from the  Department of  Law                                                               
budget;  although  the  settlement  negotiations  and  subsequent                                                               
settlements would  appear as  a budget  request from  the general                                                               
fund.                                                                                                                           
                                                                                                                                
3:59:34 PM                                                                                                                    
                                                                                                                                
DON  HABEGER, Community  Coordinator,  Juneau Reentry  Coalition,                                                               
referred  to  a  pamphlet  [Included  in  members'  packets]  and                                                               
explained that  the Juneau Reentry Coalition  was a collaboration                                                               
of  individuals,  community  stakeholders,  public  and  not  for                                                               
profit  agencies,  and  faith-based business  partners  who  were                                                               
united  in commitment  to  reduce  recidivism among  ex-offenders                                                               
returning  to the  community of  Juneau.   He  reported that  the                                                               
coalition was a  small group effort that got started  in 2013 and                                                               
grew  into  a  larger  effort with  a  steering  team,  community                                                               
membership,  and eight  different work  groups, which  he listed.                                                               
When the  work group  reports come back  to the  coalition, there                                                               
was  work to  resolve these  issues.   He  mentioned the  current                                                               
partnerships with  the Alaska Mental Health  Trust Authority, the                                                               
Department  of  Corrections, and  the  Department  of Health  and                                                               
Social Services.   He  noted that  these partnerships  included a                                                               
re-entry  case  manager  from Department  of  Health  and  Social                                                               
Services who  worked with Department of  Corrections, utilizing a                                                               
pre-release form for  work on all the issues  and services needed                                                               
to  enter the  community successfully.   He  reported that,  upon                                                               
release,  a plan  for securing  resources and  successful use  of                                                               
supports and treatments was put into place.                                                                                     
                                                                                                                                
4:05:28 PM                                                                                                                    
                                                                                                                                
DIANE  CASTO,  Behavioral  Health  Policy  Advisor,  Division  of                                                               
Behavioral  Health, Department  of  Health  and Social  Services,                                                               
expressed support for  the proposed bill, and  explained that the                                                               
proposed  bill  mentioned the  Department  of  Health and  Social                                                               
Services  for mental  health  services, including  post-traumatic                                                               
stress  disorders,  and  for re-entry  services.    She  directed                                                               
attention  to  the  10  years  of state  funded  coverage.    She                                                               
reported that  re-entry work  was already  in progress,  and that                                                               
Medicaid  Expansion   had  provided   coverage  for   almost  all                                                               
individuals  leaving  the  correctional system,  offering  mental                                                               
health services and Medicaid services.   She noted that there was                                                               
a  re-entry  center  in  Anchorage   for  partners,  as  well  as                                                               
coalitions in Fairbanks,  Matanuska-Susitna, Juneau, Kenai, Nome,                                                               
and Anchorage.  She added  that there was active solicitation for                                                               
three additional communities,  which included Dillingham, Bethel,                                                               
and Ketchikan.  She explained  that these coalitions were a group                                                               
of people, services,  and agencies in the  community committed to                                                               
doing  this  work and  ensuring  that  individuals had  the  best                                                               
opportunity  possible when  leaving  a correctional  institution.                                                               
She  listed   jobs,  housing,  and   treatment  as   the  highest                                                               
priorities for individuals.                                                                                                     
                                                                                                                                
MS.  CASTO moved  on to  discuss  the proposal  for state  funded                                                               
health coverage  for 10  years and offered  her belief  that this                                                               
had to be equivalent to  medical assistance services available in                                                               
AS 47.07.030,  the Medicaid program.   She  offered clarification                                                               
for  what was  currently doable  and  what might  be doable  even                                                               
though it  had not  yet been  fully examined.   She  relayed that                                                               
most individuals covered  by the proposed bill  would be Medicaid                                                               
eligible, as the compensation would  be tax deductible and "would                                                               
not count  against this individual being  eligible for Medicaid."                                                               
This  would allow  for immediate  enrollment,  with coverage  for                                                               
treatment  and  health care  services.    She explained  that  it                                                               
became  more complicated  as they  began to  make more  money, as                                                               
they would move  out of the eligibility range for  Medicaid.  She                                                               
pointed  out that  it would  become necessary  to determine  what                                                               
kind of  insurance coverage  was intended  in the  proposed bill.                                                               
She  offered  the  possibility for  the  Division  of  Insurance,                                                               
(Department   of  Administration),   to   purchase  health   care                                                               
equivalent  to  Medicaid.    She  suggested  that  a  state  only                                                               
Medicaid funded program, solely for  this use which would not use                                                               
federal money, could be set up.   She declared a need for this to                                                               
be further examined  so that the Department of  Health and Social                                                               
Services (DHSS) was clear for  its responsibilities.  She pointed                                                               
out that DHSS did not offer any insurance other than Medicaid.                                                                  
                                                                                                                                
4:14:12 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced that HB 118 would be held over.                                                                       
                                                                                                                                
          SB 32-PRESCRIPTIONS FOR BIOLOGICAL PRODUCTS                                                                       
                                                                                                                                
4:14:22 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced that the  final order of business would                                                               
be SENATE BILL  NO. 32, "An Act relating  to biological products;                                                               
relating to  the practice of  pharmacy; relating to the  Board of                                                               
Pharmacy; and providing for an effective date."                                                                                 
                                                                                                                                
4:15:12 PM                                                                                                                    
                                                                                                                                
SENATOR SHELLEY HUGHES, Alaska State Legislature, paraphrased                                                                   
from the Sponsor Statement [Included in members' packets], which                                                                
read:                                                                                                                           
                                                                                                                                
     Senate Bill  32 allows for  Alaskans to have  access to                                                                    
     safe,  new,  and  effective  treatment  options  called                                                                    
     interchangeable  biological   products.  Under  current                                                                    
     state  law, pharmacists  are  allowed  to substitute  a                                                                    
     generic product  for drugs that are  identical to their                                                                    
     proprietary  product  but  cannot   do  the  same  with                                                                    
     interchangeable  biological  products.   Under  SB  32,                                                                    
     pharmacists will  be able to  dispense an  FDA approved                                                                    
     interchangeable  product   as  a  substitute   for  the                                                                    
     proprietary biological product.                                                                                            
                                                                                                                                
     Due  to   the  complexity  and  nature   of  biological                                                                    
     products,  an  exact  replication  of  these  drugs  is                                                                    
     impossible,  so  a   new  category  of  interchangeable                                                                    
     products was created by the  FDA. This category of drug                                                                    
     allows for pharmaceutical companies  to create safe and                                                                    
     affordable  substitutes  for   drugs  that  help  treat                                                                    
     conditions   including   cancer,  multiple   sclerosis,                                                                    
     severe rheumatoid  arthritis, heart disease,  and other                                                                    
     immune system, neurological and hematologic disorders.                                                                     
                                                                                                                                
     In  addition to  the  clear benefits  to patients,  the                                                                    
     lower   costs  and   competition   should  also   bring                                                                    
     measurable costs  savings to Alaska's  Medicaid program                                                                    
     and  budget.  The  Center  for  Medicare  and  Medicaid                                                                    
     Services recommends that  state Medicaid programs "view                                                                    
     the  launch  of  biosimilar biological  products  as  a                                                                    
     unique opportunity  to achieve measurable  cost savings                                                                    
     and   greater    beneficiary   access    to   expensive                                                                    
     therapeutic treatments for chronic conditions."                                                                            
                                                                                                                                
     SB  32 allows  pharmacists to  dispense interchangeable                                                                    
     biological products  if they communicate this  with the                                                                    
     prescribing doctor. This bill  only allows a pharmacist                                                                    
     to  substitute  an  interchangeable product  if  it  is                                                                    
     approved  by the  FDA,  and it  allows  for doctors  to                                                                    
     require   the   pharmacist   to   only   dispense   the                                                                    
     proprietary  product   if  they  feel  it   is  a  more                                                                    
     effective   option.  Patient   consent  will   also  be                                                                    
     required  before  any  substitution   is  made  for  an                                                                    
     interchangeable over the proprietary product.                                                                              
                                                                                                                                
     It is  important for Alaska  to address this  issue now                                                                    
     as  more interchangeable  products become  available to                                                                    
     patients.  Senate  Bill  32  will  allow  for  new  and                                                                    
     effective   options   at    a   lower   cost,   without                                                                    
     jeopardizing  patient   safety,  and  will   allow  for                                                                    
     measurable Medicaid  and budget savings for  the State.                                                                    
     Please  join  in  supporting access  to  an  affordable                                                                    
     medication option for Alaskans.                                                                                            
                                                                                                                                
SENATOR  HUGHES  reported that  31  states  had already  adjusted                                                               
statutes  to  allow  for  these  bio-similars  when  they  became                                                               
available,  and  that competition  should  make  these much  more                                                               
affordable  than  the  original.   She  read:    "state  Medicaid                                                               
programs should view the launch  of bio-similar biologic products                                                               
as a  unique opportunity to  achieve measurable cost  savings and                                                               
greater  beneficiary access  to expansive  therapeutic treatments                                                               
for  chronic conditions."   She  reiterated that  there were  the                                                               
original  biologic products,  the bio-similar  products, and  now                                                               
the  interchangeable product.   The  proposed bill  would clarify                                                               
this in  statute to  allow for a  pharmacist to  substitute, with                                                               
patient consent and notification to  the prescriber.  She pointed                                                               
out  that  this  proposed  bill offered  equal  control  to  both                                                               
pharmacists and physicians.                                                                                                     
                                                                                                                                
4:22:07 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE KITO  asked about the character  of the biologics.                                                               
He said that  the generic drug replacement for a  name brand drug                                                               
had  the   exact  same   chemical  make-up.     He   offered  his                                                               
understanding that  patents did  not allow  biologics to  use the                                                               
same process or  procedure, even though they were  aiming for the                                                               
same result.   He asked if there were recognitions  for how these                                                               
act or  react to different  people.  He  asked if these  were the                                                               
same  drug  or different,  or  similar  enough to  be  considered                                                               
similar to a generic.                                                                                                           
                                                                                                                                
SENATOR HUGHES  said that  the cells, as  they were  derived from                                                               
living organisms, would  never be identical.  Even  with the same                                                               
process, these  would be "incredibly similar  but not identical."                                                               
She noted  that this  was part  of the  thorough FDA  testing for                                                               
this new  category.  She  declared that  the drugs would  have to                                                               
reach  a  level of  no  clinical  difference  in results  to  the                                                               
original or the interchangeable drugs.                                                                                          
                                                                                                                                
4:24:19 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  SULLIVAN-LEONARD asked  about the  aspect of  the                                                               
bio-chemical use  for pharmaceuticals, and whether  this included                                                               
blood born pathogens or blood products.                                                                                         
                                                                                                                                
4:25:03 PM                                                                                                                    
                                                                                                                                
THOMAS  FELIX, M.D.,  AMGEN, explained  that  the definition  for                                                               
biologics  in  federal  statute  was  very  broad,  and  included                                                               
vaccines  and blood  products and  components.   He  said it  was                                                               
important  to realize  that blood  components were  not currently                                                               
being considered for bio-similar development.   He noted that the                                                               
focus  was for  products created  in  a living  cell that  either                                                               
mimicked something already existing in  our body such as insulin,                                                               
or  something  that targeted  a  pathway  of disease  that  would                                                               
interfere with  a cell cycle for  growth related to a  tumor cell                                                               
or a growth around a tumor.                                                                                                     
                                                                                                                                
REPRESENTATIVE  SULLIVAN-LEONARD asked  if  stem  cells would  be                                                               
interspersed in this biological system.                                                                                         
                                                                                                                                
DR. FELIX,  in response, said  that stem cells were  biologics in                                                               
terms  of  concepts, but  bio-similars  would  not be  stem  cell                                                               
therapies.    He   explained  that  stem  cells   were  what  was                                                               
administered to a patient as  therapy, whereas biologics and bio-                                                               
similars were  derived from  cells, which  were not  embryonic or                                                               
human  cells,  to  make  it  produce a  protein  which  was  then                                                               
isolated, purified from  the cell, and injected  into the patient                                                               
as a therapy.                                                                                                                   
                                                                                                                                
4:27:25 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ asked  if all insulin were derived  from the same                                                               
original  set  of  cells,  and therefore  not  a  bio-similar  or                                                               
biologic interchangeable.                                                                                                       
                                                                                                                                
DR. FELIX  pointed out that  insulins were covered by  a separate                                                               
legal  and  regulatory  pathway,  the  Federal  Food,  Drug,  and                                                               
Cosmetic Act.   By 2020, these insulins would be  rolled into the                                                               
legal  and  regulatory pathway  for  approval  of biologics,  the                                                               
Public  Health Service  Act.    He shared  that  the history  for                                                               
making  insulins  had  evolved  over  time,  as  it  used  to  be                                                               
collected  from animals,  whereas now  a cell  was programmed  to                                                               
produce the insulin  more closely to a human insulin.   He shared                                                               
that  there  was a  spectrum  of  complexity  of other  types  of                                                               
biologics which were  more complex than insulin.   He pointed out                                                               
that a standard biologic technology  called a monoclonal antibody                                                               
was used,  which could target a  pathway of disease or  a healthy                                                               
pathway.                                                                                                                        
                                                                                                                                
4:29:56 PM                                                                                                                    
                                                                                                                                
CHAIR  SPOHNHOLZ asked  if insulin  had  been traditionally  held                                                               
under  an older  regulatory model  and,  in 2020,  this would  be                                                               
rolled into the more modern laws which related to biologics.                                                                    
                                                                                                                                
DR.  FELIX expressed  his agreement  and said  that insulins  and                                                               
other older  biologics which  had been approved  a long  time ago                                                               
and were much  simpler would be transitioned, with  a very strict                                                               
scientific standard  for inclusion based  on the number  of amino                                                               
acids each contained.                                                                                                           
                                                                                                                                
CHAIR  SPOHNHOLZ   reflected  on   the  definition   of  biologic                                                               
interchangeables,   which  were   designed  to   have  the   same                                                               
therapeutic  outcome,  even  though  they were  not  exactly  100                                                               
percent  replicable.     She  asked   if  this  was   related  to                                                               
proprietary law or if it was a biological limitation.                                                                           
                                                                                                                                
DR. FELIX explained that when  a bio similar was developed, there                                                               
was  not  a  recipe  book  for the  process  to  manufacture  the                                                               
original, hence  the need  to reverse  engineer from  an original                                                               
reference  products vial  or injection  device.   He shared  that                                                               
keeping an  understanding of the intellectual  property landscape                                                               
in  mind would  include, in  the development,  an approach  for a                                                               
slight  structural  variation  whether  or not  it  had  clinical                                                               
significance  that was  important.   He  pointed  out that,  once                                                               
approved, these would  be highly similar to  an existing product.                                                               
He emphasized that this was  very different than the way generics                                                               
were  approved,  as  they  typically  did  not  require  clinical                                                               
trials.  He said that it  would require clinical trials for a bio                                                               
similar or for an interchangeable biologic product.                                                                             
                                                                                                                                
CHAIR SPOHNHOLZ mused  that there was both a  cellular reason for                                                               
difference as well as for  avoidance of conflict for intellectual                                                               
property.                                                                                                                       
                                                                                                                                
4:34:20 PM                                                                                                                    
                                                                                                                                
AIMEE  BUSHNELL,  Staff,  Senator Shelley  Hughes,  Alaska  State                                                               
Legislature,  paraphrased from  the Sectional  Analysis [Included                                                               
in members' packets], which read:                                                                                               
                                                                                                                                
      Sec. 1  AS 08.80.030 Adds a new subsection requiring                                                                    
      the Board of Pharmacy to have a link on the board's                                                                       
     website   to   the   United  States   Food   and   Drug                                                                    
     Administration's     (FDA)     list     of     approved                                                                    
     interchangeable biological products.                                                                                       
                                                                                                                                
     Sec. 2   AS 08.80.294  Amends this section by requiring                                                                  
     a pharmacist  to include on  the label of  a biological                                                                    
     product  container the  proprietary or  proper name  of                                                                    
     the  biological  product.  This section  also  includes                                                                    
     language to  differentiate between  drugs that  are and                                                                    
     are  not biological  products to  ensure that  statutes                                                                    
     regarding    equivalent   generic    drugs   are    not                                                                    
     substantively changed.                                                                                                     
                                                                                                                                
     Sec. 3    AS 08.80.294 Adds a new  subsection to define                                                                  
     the  term "proper  name" being  the name  that reflects                                                                    
     scientific  characteristics  of a  biological  product.                                                                    
     This  new subsection  also  defines "proprietary  name"                                                                    
     which  is the  trademarked and  registered name  of the                                                                    
     product.                                                                                                                   
                                                                                                                                
     Sec. 4    AS 08.80.295  Adds language  to differentiate                                                                  
     between  equivalent drug  products and  interchangeable                                                                    
     biological products.                                                                                                       
                                                                                                                                
     Sec. 5    AS 08.80.295 Adds new  subsections to provide                                                                  
     guidelines  as to  how  pharmacists  or their  designee                                                                    
     will  need to  communicate  with  a prescribing  doctor                                                                    
     when   dispensing  a   biological  or   interchangeable                                                                    
     biological  product if  an  interchangeable product  is                                                                    
     available.                                                                                                                 
                                                                                                                                
     Under subsection (c), a  pharmacist must communicate to                                                                    
     the  prescribing doctor  the name  and manufacturer  of                                                                    
     the biological  product provided  to the  patient. This                                                                    
     communication  must  happen  within  three  days  after                                                                    
     dispensing  the   product  by   an  entry   through  an                                                                    
     interoperable  electronic  medical records  system,  an                                                                    
     electronic prescribing  technology, a  pharmacy benefit                                                                    
     management system,  or a pharmacy  record. If  an entry                                                                    
     under this  subsection is not possible,  the pharmacist                                                                    
     may communicate  by e-mail, telephone,  fax, or  by any                                                                    
     other prevailing means.                                                                                                    
                                                                                                                                
     Under  subsection  (d)  provides an  exception  to  the                                                                    
     communication  requirement under  (c) if  the dispensed                                                                    
     biological product is a refill  of the prescription and                                                                    
     is   the  same   biological  product.   Subsection  (e)                                                                    
     provides  that communication  provided under  (c)(1) of                                                                    
     this  section is  providing notice  to the  prescribing                                                                    
     doctor. Under subsection (f),  a pharmacist is required                                                                    
     to maintain a  record for two years  after a biological                                                                    
     product  is dispensed.  Finally subsection  (g) defines                                                                    
     "designee" as an agent or  employee of a pharmacist who                                                                    
     has  been authorized  to communicate  information under                                                                    
     subsection (c).                                                                                                            
                                                                                                                                
     Sec. 6    AS 08.80.480(34) Changes  language, and gives                                                                  
     option to change the term  "drug" and "equivalent drug"                                                                    
     to    "biological    product"   and    "interchangeable                                                                    
     biological product".                                                                                                       
                                                                                                                                
     Sec. 7 AS 08.80.480 Adds  new subsection (37) to define                                                                  
     term "biological product". Adds  new subsection (36) to                                                                    
     define term  "interchangeable biological product"  as a                                                                    
     biological product  as determined by the  United States                                                                    
     Food  and  Drug  Administration. Under  subsection  (A)                                                                    
     provides    that   it    meets    the   standard    for                                                                    
     interchangeability   under  US   code  (Regulation   of                                                                    
     biological products,  Safety standards  for determining                                                                    
     interchangeability).  Under   subsection  (B)  provides                                                                    
     that  it  is  therapeutically equivalent  in  the  most                                                                    
     recent  edition  of the  United  States  Food and  Drug                                                                    
     Administration evaluations.                                                                                                
                                                                                                                                
     Sec.  8  AS 08.80.480  Amends  this  section by  adding                                                                  
     transition  regulations   if  necessary   to  implement                                                                    
     changes made by this Act.  Having changes take place in                                                                    
     accordance  with  AS  44.62  (Administrative  Procedure                                                                    
     Act) but not before the effective date of this Act.                                                                        
                                                                                                                                
     Sec. 9  AS 08.80.480  Adds language  that section  8 of                                                                  
     this Act takes effect July 1, 2017.                                                                                        
                                                                                                                                
     Sec. 10 AS  08.80.480 Adds language that  this Act will                                                                  
     take effect January  1, 2018, except for  a provided in                                                                    
     section 9.                                                                                                                 
                                                                                                                                
                                                                                                                                
MS.  BUSHNELL stated  that  there were  also  several letters  of                                                               
support,  including from  the Alaska  State Hospital  and Nursing                                                               
Home  Association  (ASHNHA) and  from  the  Alaska State  Medical                                                               
Association (ASMA).  She pointed  out that ASMA had first written                                                               
a letter  of neutrality and,  subsequently, had written  a letter                                                               
of support for the proposed bill.                                                                                               
                                                                                                                                
4:36:21 PM                                                                                                                    
                                                                                                                                
CHAIR SPOHNHOLZ announced that SB 32 would be held over.                                                                        
                                                                                                                                
4:37:05 PM                                                                                                                    
                                                                                                                                
ADJOURNMENT                                                                                                                   
                                                                                                                                
There being no further business before the committee, the House                                                                 
Health and Social Services Standing Committee meeting was                                                                       
adjourned at 4:37 p.m.                                                                                                          

Document Name Date/Time Subjects
HB 159 Sectional Analysis ver A 3.6.17.pdf HHSS 3/18/2017 3:00:00 PM
HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB0159 ver A 3.6.17.pdf HHSS 3/18/2017 3:00:00 PM
HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB159 Fiscal Note DHSS-PHAS 3.6.17.pdf HHSS 3/18/2017 3:00:00 PM
HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB159 Sponsor Statement 3.6.17.pdf HHSS 3/18/2017 3:00:00 PM
HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB159 Supporting Document - Letter from Alaska Dental Society.pdf HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB159 Supporting Document - PDMP side by side comparison 3.23.17.pdf HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB159 Supporting Document - Opioid Bill FAQ 3.23.17.pdf HHSS 3/25/2017 3:00:00 PM
HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB 159 Governor's Amendment.pdf HHSS 3/30/2017 3:00:00 PM
HHSS 4/4/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB 159 Draft Proposed Proposed Amendment J.1 4.6.2017.pdf HHSS 4/8/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB 159 Draft Proposed Blank CS ver J 4.6.2017.pdf HHSS 4/8/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 159
HB025 Sectional Analysis ver A 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Opposing Document-Letter NFIB 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Sponsor Statement 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-ADN Commentary 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Cost Savings Study 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Guttmacher Alaska Statistics 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Guttmacher Public Costs from Unintended Pregnancies 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-HB025 Support Emails 2.27.17.pdf HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter Kachemak Bay Family Planning Clinic 2.23.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter League of Women Voters Alaska 2.24.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-UCSF Study Newspaper Article 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Unintended Pregnancies Study 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 ver A 2.16.17.PDF HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter Planned Parenthood Votes Northwest & Hawaii 2.16.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Fiscal Note DHSS-DHCS 2.28.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Fiscal Note DCCED-DIO 2.28.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Opposing Document-America's Health Insurance Plans 2.27.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter Dr. Tina Tomsen 2.27.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Support Emails 2.27.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Fiscal Note DHSS-Medicaid Services 2.28.17.pdf HHSS 2/28/2017 3:00:00 PM
HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-HB025 Support Emails 3.7.17.pdf HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Opposing Document-Letters of Opposition 3.8.2017.pdf HHSS 3/9/2017 3:00:00 PM
HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Summary of Changes ver J 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Proposed Blank CS ver J 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-HB025 Support Emails 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter Alaska Pharmacists Association 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter ANDVSA 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter APRN Alliance 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
HB025 Supporting Document-Letter Tanana Chiefs Conference 4.5.17.pdf HHSS 4/6/2017 3:00:00 PM
HHSS 4/11/2017 3:00:00 PM
HB 25
SB032 Fiscal Note DOCCED 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
SB 32
SB032 Sectional Analysis ver J 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
SB 32
SB032 Opposing Document-Opposition Letters 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
SB 32
SB032 Sponsor Statement 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
SB 32
SB032 Supporting Documents-Support Letters 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
SB 32
SB032 ver J 04.04.17.pdf HHSS 4/11/2017 3:00:00 PM
SB 32
HB 118 Sponsor Satement 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Document - Doyon support letter 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Document - Medical Compsensation by State 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Document - PBS Article 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Document - Support letters 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Document - TCC letter of support 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Supporting Documents 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 ver A 4.10.2017.PDF HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Fiscal Note DHSS--BHTRG 4.10.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Fiscal Note DOL--CJL 4.10.17.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118
HB 118 Sectional Analysis ver A 4.10.2017.pdf HHSS 4/11/2017 3:00:00 PM
HHSS 4/13/2017 3:00:00 PM
HB 118